Status:
ACTIVE_NOT_RECRUITING
A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
Lead Sponsor:
Roswell Park Cancer Institute
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
Cardiovascular Disorder
Coronary Artery Disease
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This clinical trial develops and tests a culturally-appropriate educational program (Indigenous SIPin) for reducing sugar-sweetened beverage consumption in men affiliated with Native American athletic...
Detailed Description
PRIMARY OBJECTIVE: I. Conduct and analyze qualitative data from focus groups and key informant interviews with Native American community members including Native American leaders and community member...
Eligibility Criteria
Inclusion
- At least 18 years or older
- Research conducted on tribal lands require tribal government approval. Our project will not be occurring on tribal lands. The project will be working with Native organizations off-territory
- Participants only must own a smart device in order to receive study text messages
- At least 18 years or older
- Research conducted on tribal lands require tribal government approval. Our project will not be occurring on tribal lands. The project will be working with Native organizations off-territory
- Participants only must own a smart device in order to receive study text messages
Exclusion
- Research conducted on tribal lands require tribal government approval. Since we do not currently have tribal government approval, our project will not be occurring on tribal lands
Key Trial Info
Start Date :
July 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2026
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06029517
Start Date
July 20 2022
End Date
September 15 2026
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States, 14263